InvestorsHub Logo
Followers 78
Posts 10240
Boards Moderated 9
Alias Born 06/06/2017

Re: None

Tuesday, 02/09/2021 8:29:04 AM

Tuesday, February 09, 2021 8:29:04 AM

Post# of 8305
$TNXP Plans To Develop COVID-19 Skin Test.

What happened Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) jumped 22% on Monday after the biopharmaceutical company said it would develop a COVID-19 skin test. So what Tonix intends to develop a diagnostic skin test, called TNX-2100, to measure T-cell immunity to SARS-CoV-2, the virus that causes COVID-19.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News